September Asthma Peak
Price: FREE for members and non-members
Session recorded on August 26, 2021
Speaker: Jeremy Katcher, MD
Viewers can earn credit by completing the posttest questions
This program is a collaboration between the American College of Allergy, Asthma and Immunology and the Allergy and Asthma Network.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Providers
Upon completion of this activity learners should be able to:
1. Recognize the continued value of virtual care.
2. Recognize the changing telemedicine regulatory landscape.
3. Review optimized workflows for virtual care implementation.
All identified conflicts of interest have been resolved.
Michael Blaiss, MD, Planner
Disclosures: Consultant: ALK, DBV, Hycor, Merck, Pfizer, Sanofi, Stallergenes Greer, PMD Healthcare
Jeremy Katcher, MD, Speaker
Disclosures: Speaker: Teva
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance